CN215995153U - Subcutaneous fat hyperplasia grid positioning card caused by insulin injection - Google Patents

Subcutaneous fat hyperplasia grid positioning card caused by insulin injection Download PDF

Info

Publication number
CN215995153U
CN215995153U CN202120805115.3U CN202120805115U CN215995153U CN 215995153 U CN215995153 U CN 215995153U CN 202120805115 U CN202120805115 U CN 202120805115U CN 215995153 U CN215995153 U CN 215995153U
Authority
CN
China
Prior art keywords
injection
cover plate
marking
plate body
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN202120805115.3U
Other languages
Chinese (zh)
Inventor
夏静
余莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yixing Peoples Hospital
Original Assignee
Yixing Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yixing Peoples Hospital filed Critical Yixing Peoples Hospital
Priority to CN202120805115.3U priority Critical patent/CN215995153U/en
Application granted granted Critical
Publication of CN215995153U publication Critical patent/CN215995153U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The utility model discloses a subcutaneous hyperplasia of fat grid positioning card caused by insulin injection, which relates to the technical field of insulin injection and comprises an injection plate body and a marking cover plate, wherein penetrating injection holes are uniformly formed in the injection plate body; the upper surface of the marking cover plate is uniformly provided with transverse marking lines and longitudinal marking lines, the marking cover plate is provided with holes, and the lower surface of the marking cover plate is provided with a flange. The utility model has simple structure, easy operation, convenient injection for users, difficult sliding after the human body is fixed, repeated use, excellent positioning effect and marking effect, wide suitable injection position, strong practicability and suitable popularization.

Description

Subcutaneous fat hyperplasia grid positioning card caused by insulin injection
Technical Field
The utility model belongs to the technical field of insulin injection, and particularly relates to a subcutaneous fat hyperplasia grid positioning card caused by insulin injection.
Background
Insulin is the only hormone in the body which reduces blood sugar and promotes the synthesis of glycogen, fat and protein. Exogenous insulin is mainly used for treating diabetes. In the current clinical medicine, the corresponding injection site is selected according to the type of insulin used. I.e. using short-acting insulin or insulin mixed with intermediate-acting insulin, the preferred injection site is the abdomen. For medium-acting insulins, such as those injected before bedtime, the most suitable injection site is the buttocks or thighs, and each injection site should be at least 1 cm from the last injection site. The grid positioning card is convenient for a user to inject, can be repeatedly used, has excellent positioning effect and marking effect and is suitable for injection at a wide position.
SUMMERY OF THE UTILITY MODEL
The utility model aims to provide a subcutaneous fat hyperplasia grid positioning card caused by insulin injection, which has the advantages of simple structure, easy operation, convenient injection by a user, no sliding after the human body is fixed, repeated use, excellent positioning effect and marking effect, wide suitable injection position, strong practicability and suitability for popularization.
The utility model provides the following technical scheme: a subcutaneous lipohypertrophy grid positioning card caused by insulin injection comprises an injection plate body and a marking cover plate, wherein penetrating injection holes are uniformly formed in the injection plate body, a circle of fixing groove is formed in the edge of the upper surface of the injection plate body, handheld plates are symmetrically and fixedly arranged on two sides of the injection plate body, binding belts are symmetrically and fixedly arranged on the outer side surfaces of the handheld plates, rubber sheets are symmetrically and fixedly arranged on two sides of the injection plate body, and clamping bulges are arranged above the injection plate body by the rubber sheets and the handheld plates;
the injection hole is formed in the position, corresponding to the fixing groove, of the lower surface of the mark cover plate, and the horizontal mark line and the longitudinal mark line are uniformly arranged on the upper surface of the mark cover plate.
Preferably, the injection plate body is a transparent flexible plate body.
Preferably, the indicia cover is provided in plurality and is formed from a flexible transparent plastic sheet.
Preferably, the injection hole is matched with the shape of the opening, a sealing cover is arranged in the opening, and the sealing cover is connected with the mark cover plate in an adhesive mode.
Preferably, the marking cover plate is provided with a plurality of marking cover plates according to different use positions, the number of the openings on different marking cover plates is different from the number of the cover sealing positions, the center of the marking cover plate is provided with a positioning hole, and the openings are all corresponding to the injection holes.
Preferably, the outer side edge of the indicia cover is complementary to the inner side edge of the snap-in projection.
The utility model has the beneficial effects that: simple structure, easily operation, the person of facilitating the use injection should not slide after human body is fixed, can use repeatedly, and positioning effect, marking effect are excellent, and the position that is suitable for the injection is extensive, and the practicality is strong, specifically as follows:
(1) the utility model is provided with an injection plate body, the injection plate body is fixed at a required position through a binding belt, a rubber sheet is pasted on the skin to provide friction force, so that the injection plate body is not easy to slide when being pasted on the skin, the injection plate body is provided with a fixed groove and a clamping bulge, a required mark cover plate is combined and fixed on the injection plate body through a flange and the fixed groove, and the edge of the mark cover plate is combined with the clamping bulge at the moment, so that the connection between the mark cover plate and the injection plate body is tighter.
(2) The utility model is provided with a marking cover plate, the marking cover plate is provided with a positioning hole according to different use parts, when the insulin injection part is the belly, the positioning hole is aligned to the navel, because the injection can not be carried out around the navel, no opening is arranged around the positioning hole, when the injection part is positioned at the positions of thighs or buttocks and the like, the marking cover plate without the positioning hole is adopted, and various marking cover plates are suitable for different parts of a human body.
(3) The injection plate body and the marking cover plate are made of transparent materials and are convenient to calibrate, the holes with the sealing covers are all non-injection parts and are convenient to confirm by a user, the marking cover plate is provided with a plurality of flexible transparent plastic sheets, so that the marking cover plate is low in cost and convenient to use, and after the holes in the marking cover plate are used up, the marking cover plate is taken out from the clamping bulges and the fixed groove and is replaced.
Drawings
The accompanying drawings, which are included to provide a further understanding of the utility model and are incorporated in and constitute a part of this specification, illustrate embodiments of the utility model and together with the description serve to explain the principles of the utility model and not to limit the utility model. In the drawings:
FIG. 1 is an overall schematic view of the present invention;
FIG. 2 is a bottom view of the indicia cover of the present invention;
FIG. 3 is an overall top view of the present invention;
FIG. 4 is a schematic view of a cover patch for the navel of the present invention;
labeled as: the injection mould comprises an injection plate body 1, a marking cover plate 2, an injection hole 3, a fixing groove 4, a handheld plate 5, a rubber sheet 6, a clamping bulge 7, an opening 8, a binding belt 9, a transverse marking line 10, a longitudinal marking line 11, a flange 12, a positioning hole 13 and a sealing cover 14.
Detailed Description
The utility model will be further illustrated with reference to the following specific examples. These examples are intended to illustrate the utility model and are not intended to limit the scope of the utility model. In the description of the present invention, it is to be noted that, unless otherwise explicitly specified or limited, the terms "mounted", "provided" and "connected" are to be interpreted broadly, e.g. as a fixed connection, a detachable connection or an integral connection; can be mechanically or electrically connected; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meanings of the above terms in the present invention can be understood in specific cases to those skilled in the art.
The structural features of the present invention will now be described in detail with reference to the accompanying drawings.
Referring to fig. 1, a subcutaneous fat hyperplasia mesh positioning card caused by insulin injection comprises an injection plate body 1 and a marking cover plate 2, wherein injection holes 3 are uniformly formed in the injection plate body 1 and are used for injection through the injection holes 3, a circle of fixing grooves 4 are formed in the edge of the upper surface of the injection plate body 1, the marking cover plate 2 is fixed on the injection plate body 1 through the clamping connection of the fixing grooves 4 and a flange 12, handheld plates 5 are symmetrically and fixedly arranged on two sides of the injection plate body 1, binding bands 9 are symmetrically and fixedly arranged on the outer side surfaces of the handheld plates 5, the injection plate body 1 is fixed at corresponding positions through the handheld plates 5 and the binding bands 9, the positions are determined by the used injection holes 3 and needle holes, rubber sheets 6 are symmetrically and fixedly arranged on two sides of the injection plate body 1, and friction force is provided by the rubber sheets 6 when the injection plate body is attached to the skin, so that the injection plate body 1 is not suitable for sliding when being attached to the skin, rubber sheet 6, handheld board 5 are equipped with card and are gone into protruding 7 in injection plate body 1 top, and the outside limit of mark cover plate 2 matches each other with the inboard limit of going into protruding 7, and it is inseparabler to make to be connected between mark cover plate 2 and the injection plate body 1.
Referring to fig. 2, the upper surface of the marking cover plate 2 is uniformly provided with transverse marking lines 10 and longitudinal marking lines 11, the distance between injection positions in a short period of time of insulin according to medical regulations must exceed 1 cm to prevent subcutaneous fat hyperplasia, each transverse marking line 10 is 2 cm apart, each longitudinal marking line 11 is 2 cm apart, the marking cover plate 2 is provided with an opening 8 matched with the size of the injection hole 3 at the crossing position of the transverse marking lines 10 and the longitudinal marking lines 11, and the lower surface of the marking cover plate 2 corresponding to the fixing groove 4 is provided with a flange 12 matched with the opening.
The injection plate body 1 is a transparent flexible plate body, the marking cover plate 2 is provided with a plurality of flexible transparent plastic sheets, so that a user can conveniently confirm the injection position, and the marking cover plate 2 is low in cost and convenient to use.
Referring to fig. 2, the injection hole 3 is matched with the shape of the opening 8, a sealing cover 14 is arranged in the opening 8, the sealing cover 14 is connected with the marking cover 2 in an adhering mode, the sealing cover 14 is peeled off from the marking cover 2 during injection, and the opening 8 with the sealing cover 14 is an uninjected part, so that a user can conveniently confirm the uninjected part.
Referring to fig. 2-3, the marking cover plate 2 is provided with a plurality of marking cover plates 2 according to different use positions, the number of the open holes 8 on different marking cover plates 2 is different from that of the seal cover 14 for specific use conditions, the center of the marking cover plate 2 is provided with a positioning hole 13, when the insulin injection position is the belly, the positioning hole 13 is aligned to the navel, the injection cannot be performed around the navel, the open holes 8 are not arranged around the positioning hole 13, and the open holes 8 correspond to the injection holes 3.
The subcutaneous fat hyperplasia grid positioning card caused by insulin injection has the advantages of simple structure, easy operation, convenient injection by a user, no sliding after the human body is fixed, repeated use, excellent positioning effect and marking effect, wide suitable injection position, strong practicability and suitable popularization.
Specifically, referring to fig. 1-2, the injection plate body 1 is fixed at a desired position by a binding tape 9, the rubber sheet 6 is attached to the skin, so that the injection plate body 1 is not easy to slide when attached to the skin, the desired marking cover plate 2 is fixed to the injection plate body 1 by combining the flange 12 with the fixing groove 4, and the edge of the marking cover plate 2 is combined with the snapping protrusions 7, so that the marking cover plate 2 is tightly connected with the injection plate body 1.
Referring to fig. 2 to 4, according to the use site, when the insulin injection site is the abdomen, the positioning hole 13 is aligned with the navel, and when the injection site is located at the thigh or the hip, etc., the marking cover sheet 2 without the positioning hole 13 is used, and different marking cover sheets 2 are used for different parts of the human body.
Referring to fig. 1-2, when a user uses the injection plate body 1 to inject, the open hole 8 is tightly attached to the upper side of the injection hole 3, a sealing cover 14 is arranged in the unused open hole 8, the sealing cover 14 is detached from the mark cover 2, a needle head is injected through the open hole 8 and the injection hole 3, the used open hole 8 is aligned with the injected needle eye in the calibration process of the injection plate body 1, the open holes 8 with the sealing covers 14 are all non-injection positions, the user can conveniently confirm, the mark cover 2 is provided with a plurality of flexible transparent plastic sheets, the mark cover 2 is low in cost and convenient to use, and after the open hole 8 on the mark cover 2 is used up, the mark cover 2 is taken out from the clamping protrusion 7 and the fixing groove 4 to be replaced.
Although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the utility model. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (6)

1. The subcutaneous lipohypertrophy grid locating card caused by insulin injection comprises an injection plate body (1) and a marking cover plate (2), and is characterized in that penetrating injection holes (3) are uniformly formed in the injection plate body (1), a fixing groove (4) surrounding a circle is formed in the edge of the upper surface of the injection plate body (1), handheld plates (5) are symmetrically and fixedly arranged on two sides of the injection plate body (1), binding bands (9) are symmetrically and fixedly arranged on the outer side surfaces of the handheld plates (5), rubber sheets (6) are symmetrically and fixedly arranged on two sides of the injection plate body (1), and clamping bulges (7) are arranged above the injection plate body (1) by the rubber sheets (6) and the handheld plates (5);
the injection hole is characterized in that the upper surface of the mark cover plate (2) is uniformly provided with transverse mark lines (10) and longitudinal mark lines (11), the cross positions of the mark cover plate (2) at the transverse mark lines (10) and the longitudinal mark lines (11) are provided with holes (8) matched with the size of the injection hole (3), and the lower surface of the mark cover plate (2) corresponding to the fixing grooves (4) is provided with flanges (12) matched with the fixing grooves.
2. An insulin injection induced subcutaneous fat hyperplasia grid positioning card as claimed in claim 1, wherein, the injection plate body (1) is a transparent flexible plate body.
3. An insulin injection induced subcutaneous fat hyperplasia grid locating card as claimed in claim 1, wherein said marker cover plate (2) is provided with a plurality of and is composed of flexible transparent plastic sheets.
4. An insulin injection induced subcutaneous fat hyperplasia grid positioning card as claimed in claim 1, wherein the injection hole (3) is matched with the shape of the opening (8), a cover (14) is arranged in the opening (8), and the cover (14) is connected with the marking cover plate (2) in an adhesion mode.
5. The subcutaneous fat hyperplasia grid positioning card caused by insulin injection as claimed in claim 1, wherein the marking cover plate (2) is provided with a plurality of marking cover plates (2) according to different use positions, the number of the open holes (8) on different marking cover plates (2) is different from that of the seal covers (14), the center of the marking cover plate (2) is provided with a positioning hole (13), and the open holes (8) are all corresponding to the injection holes (3).
6. An insulin injection induced subcutaneous fat hyperplasia grid locating card as claimed in claim 1, wherein the outside edge of the marker cover plate (2) and the inside edge of the snap-in projection (7) are matched with each other.
CN202120805115.3U 2021-04-16 2021-04-16 Subcutaneous fat hyperplasia grid positioning card caused by insulin injection Expired - Fee Related CN215995153U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202120805115.3U CN215995153U (en) 2021-04-16 2021-04-16 Subcutaneous fat hyperplasia grid positioning card caused by insulin injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202120805115.3U CN215995153U (en) 2021-04-16 2021-04-16 Subcutaneous fat hyperplasia grid positioning card caused by insulin injection

Publications (1)

Publication Number Publication Date
CN215995153U true CN215995153U (en) 2022-03-11

Family

ID=80581160

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202120805115.3U Expired - Fee Related CN215995153U (en) 2021-04-16 2021-04-16 Subcutaneous fat hyperplasia grid positioning card caused by insulin injection

Country Status (1)

Country Link
CN (1) CN215995153U (en)

Similar Documents

Publication Publication Date Title
US10575859B2 (en) Hemostatic device
CN215995153U (en) Subcutaneous fat hyperplasia grid positioning card caused by insulin injection
CN204619059U (en) Clock-type parts of insulin injection bellyband
CN210933190U (en) Insulin injection positioning card
CN205849929U (en) A kind of abdominal part insulin injection positioning belt
CN212214320U (en) Insulin injection positioning device
CN209056150U (en) A kind of implanted transfusion port puncturing pattern
CN218685573U (en) Insulin injection positioning card
CN210955771U (en) Buttock intramuscular injection contrast model
CN215577121U (en) Trans-abdominal subcutaneous injection training model
CN202236646U (en) Visible children scalp needle protecting cover
CN215275123U (en) Be used for subcutaneous fat hyperplasia mark device
CN215653140U (en) Subcutaneous deltoid injection visual identification
CN219847036U (en) Electric heating salt bag hot compress bag for children
CN220256490U (en) Prostate biopsy fixing application for perineum puncture
CN215351282U (en) Smooth source multifunctional injection positioning scale
CN215425419U (en) Multifunctional abdominal belt for surgical enterostomy patient
CN210925159U (en) Skin training model
CN216394950U (en) Special abdomen hypodermic positioning card for obstetrical department
CN215839523U (en) Medical eye patch fixing cover
CN211050532U (en) Waistband for insulin injection alternate part
CN216319292U (en) Insulin injection positioning card
CN213526904U (en) Position-fixing abdominal belt for insulin injection site
CN219579588U (en) Novel keep somewhere fixed pad pasting of needle
CN211244976U (en) Abdomen injection alternate positioning card

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20220311

CF01 Termination of patent right due to non-payment of annual fee